Vascular Health Sciences announces to health care practitioners attending the conference: Let's monitor your vascular health in real time before and after taking Arterosil HP.
LONG BEACH, Calif. (PRWEB) January 04, 2013
A group of physicians and healthcare providers focused on primary care recently learned about the vital role of the endothelial glycocalyx, and a holistic approach to managing artery health.
At the Holistic Primary Care Conference in Long Beach, Vascular Health Sciences invited conference attendees to measure the health of their glycocalyx -- the thin, gel-like lining of the artery walls that acts as the first line in protecting the heart and arteries -- before and after taking Arterosil HP.
More than 50 doctors who attended the conference approached Vascular Health Sciences to conduct the non-invasive, three-minute test using new GlycoCheck technology to determine the health of their glycocalyx. They were then given sample packs of Arterosil HP. The result: Most of test subjects saw improvement in their GlycoCheck scores within 24 hours.
Through Vascular Health Sciences, Health Care Practitioners in the holistic primary care field can offer Arterosil HP through their practices. They can also learn more about where to conduct non-invasive glycocalyx testing of their own patients using GlycoCheck technology to monitor artery health through trained healthcare professionals.
For more information about Arterosil HP, visit AterosilHP.com. For more information on GlycoCheck, visit, GlycoCheck.com.
About Vascular Health Sciences
Founded in 2010, Vascular Health Sciences explores technologies, develops products and disseminates information to increase awareness and promote the proper care of the endothelial glycocalyx. Vascular Health Sciences is committed to increasing awareness of the glycocalyx and its role in vascular health, and to providing products supporting the care of this essential system. For more information, visit VascularHealthSciences.com, find Arterosil HP on Facebook.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebholisticprimarycare/arterosilhp/prweb10282682.htm
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.